Morgan Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.77 M
as on 22-12-2024
- Paid Up Capital ₹ 0.77 M
as on 22-12-2024
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.50 M
as on 22-12-2024
- Revenue 50.05%
(FY 2023)
- Profit -3.06%
(FY 2023)
- Ebitda -3.58%
(FY 2023)
- Net Worth 50.16%
(FY 2023)
- Total Assets 3.80%
(FY 2023)
About Morgan Lifesciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.77 M and a paid-up capital of Rs 0.77 M.
The company currently has active open charges totaling ₹5.50 M.
Miteshkumar Modi, Deepaben Modi, Amish Shah, and One other member serve as directors at the Company.
- CIN/LLPIN
U33100GJ2019PTC110664
- Company No.
110664
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Nov 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Morgan Lifesciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Miteshkumar Modi  | Director | 05-Nov-2019 | Current |
| Deepaben Modi | Director | 05-Nov-2019 | Current |
| Amish Shah | Director | 16-Nov-2019 | Current |
| Viral Shah | Director | 24-Feb-2022 | Current |
Financial Performance of Morgan Lifesciences.
Morgan Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 50.05% increase. The company also saw a slight decrease in profitability, with a 3.06% decrease in profit. The company's net worth Soared by an impressive increase of 50.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Morgan Lifesciences?
In 2023, Morgan Lifesciences had a public holding of 9.40%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Oct 2023 | ₹5.50 M | Open |
How Many Employees Work at Morgan Lifesciences?
Morgan Lifesciences has a workforce of 12 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Morgan Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Morgan Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
